Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

President Trump published letters to 17 major pharma companies reiterating his requirements for them to fulfill his MFN order ...

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

Eli Lilly drug Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the ...

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

A rally in stocks sputtered ahead of President Donald Trump’s tariff deadline, with the White House demanding drugmakers to ...

Novo Nordisk (NVO) was downgraded to Hold from Buy at HSBC following the company’s recent warning that its 2025 exit growth rate will likely settle into mid-single digits. This adjustment reflects ...

Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.

July's jobs report reveals mixed signals. Discover key sectors with growth momentum and risks in labor trends to ...

A rally in stocks fizzled out ahead of President Donald Trump’s tariff deadline, with the White House demanding drugmakers to ...

Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...